{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:35:55Z","timestamp":1791653755264,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.vaccine.2010.09.005","type":"journal-article","created":{"date-parts":[[2010,9,18]],"date-time":"2010-09-18T08:39:12Z","timestamp":1284799152000},"page":"7345-7350","source":"Crossref","is-referenced-by-count":46,"title":["Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primates"],"prefix":"10.1016","volume":"28","author":[{"given":"Lesley C.","family":"Dupuy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle J.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie S.","family":"Schmaljohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.09.005_bib0005","series-title":"Fields virology","first-page":"917","article-title":"Alphaviruses","author":"Griffin","year":"2001"},{"issue":"1 (November)","key":"10.1016\/j.vaccine.2010.09.005_bib0010","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/0042-6822(92)90190-Z","article-title":"Phylogenetic analysis of alphaviruses in the Venezuelan equine encephalitis complex and identification of the source of epizootic viruses","volume":"191","author":"Weaver","year":"1992","journal-title":"Virology"},{"issue":"1 (January)","key":"10.1016\/j.vaccine.2010.09.005_bib0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0025-7125(16)30270-X","article-title":"Viral encephalitis","volume":"77","author":"Bale","year":"1993","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.vaccine.2010.09.005_bib0020","series-title":"Medical aspects of biological warfare","first-page":"241","article-title":"Alphavirus encephalitides","author":"Steele","year":"2007"},{"issue":"1 (March)","key":"10.1016\/j.vaccine.2010.09.005_bib0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0891-5520(20)30389-5","article-title":"Arboviral infections in the United States","volume":"5","author":"Tsai","year":"1991","journal-title":"Infect Dis Clin North Am"},{"issue":"806 (December 8)","key":"10.1016\/j.vaccine.2010.09.005_bib0030","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1126\/science.158.3806.1283","article-title":"Arbovirus infections of laboratory workers. Extent of problem emphasizes the need for more effective measures to reduce hazards","volume":"158","author":"Hanson","year":"1967","journal-title":"Science"},{"issue":"3 (September)","key":"10.1016\/j.vaccine.2010.09.005_bib0035","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0272-2712(18)30018-0","article-title":"Clinical recognition and management of patients exposed to biological warfare agents","volume":"21","author":"Franz","year":"2001","journal-title":"Clin Lab Med"},{"issue":"July","key":"10.1016\/j.vaccine.2010.09.005_bib0040","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4269\/ajtmh.1963.12.597","article-title":"Use of an attenuated strain of Venezuelan equine encephalomyelitis virus for immunization in man","volume":"12","author":"McKinney","year":"1963","journal-title":"Am J Trop Med Hyg"},{"issue":"4 (March)","key":"10.1016\/j.vaccine.2010.09.005_bib0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0264-410X(95)00168-Z","article-title":"Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine","volume":"14","author":"Pittman","year":"1996","journal-title":"Vaccine"},{"issue":"2 (February)","key":"10.1016\/j.vaccine.2010.09.005_bib0050","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1128\/AEM.25.2.262-265.1973","article-title":"Formalin-inactivated Venezuelan equine encephalomyelitis (Trinidad strain) vaccine produced in rolling-bottle cultures of chicken embryo cells","volume":"25","author":"Cole","year":"1973","journal-title":"Appl Microbiol"},{"issue":"3 (March)","key":"10.1016\/j.vaccine.2010.09.005_bib0055","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1128\/JCM.19.3.429-431.1984","article-title":"Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters","volume":"19","author":"Jahrling","year":"1984","journal-title":"J Clin Microbiol"},{"issue":"Suppl. 4 (November 5)","key":"10.1016\/j.vaccine.2010.09.005_bib0060","doi-asserted-by":"crossref","first-page":"D80","DOI":"10.1016\/j.vaccine.2009.07.095","article-title":"Vaccines for Venezuelan equine encephalitis","volume":"27","author":"Paessler","year":"2009","journal-title":"Vaccine"},{"issue":"12 (December)","key":"10.1016\/j.vaccine.2010.09.005_bib0065","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1586\/erv.09.132","article-title":"DNA vaccines for biodefense","volume":"8","author":"Dupuy","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"25\u201326 (September 8)","key":"10.1016\/j.vaccine.2010.09.005_bib0070","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1016\/S0264-410X(03)00362-1","article-title":"Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus. Marburg virus and Venezuelan equine encephalitis virus","volume":"21","author":"Riemenschneider","year":"2003","journal-title":"Vaccine"},{"issue":"2 (February)","key":"10.1016\/j.vaccine.2010.09.005_bib0075","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/infdis\/129.2.194","article-title":"Experimental studies of rhesus monkeys infected with epizootic and enzootic subtypes of Venezuelan equine encephalitis virus","volume":"129","author":"Monath","year":"1974","journal-title":"J Infect Dis"},{"issue":"9\u201310 (May\u2013June)","key":"10.1016\/j.vaccine.2010.09.005_bib0080","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0264-410X(97)00192-8","article-title":"Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates","volume":"16","author":"Pratt","year":"1998","journal-title":"Vaccine"},{"issue":"25\u201326 (September 8)","key":"10.1016\/j.vaccine.2010.09.005_bib0085","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1016\/S0264-410X(03)00328-1","article-title":"Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models","volume":"21","author":"Pratt","year":"2003","journal-title":"Vaccine"},{"issue":"24 (May 2)","key":"10.1016\/j.vaccine.2010.09.005_bib0090","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1016\/j.vaccine.2004.12.023","article-title":"Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus","volume":"23","author":"Reed","year":"2005","journal-title":"Vaccine"},{"issue":"12 (December)","key":"10.1016\/j.vaccine.2010.09.005_bib0095","doi-asserted-by":"crossref","first-page":"9563","DOI":"10.1128\/JVI.71.12.9563-9569.1997","article-title":"Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge","volume":"71","author":"Schmaljohn","year":"1997","journal-title":"J Virol"},{"issue":"9\u201310 (March 5)","key":"10.1016\/j.vaccine.2010.09.005_bib0100","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0264-410X(98)00335-1","article-title":"Expression, processing, and immunogenicity of the structural proteins of Venezuelan equine encephalitis virus from recombinant baculovirus vectors","volume":"17","author":"Hodgson","year":"1999","journal-title":"Vaccine"},{"issue":"6 (March 15)","key":"10.1016\/j.vaccine.2010.09.005_bib0105","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1086\/382281","article-title":"Aerosol infection of cynomolgus macaques with enzootic strains of Venezuelan equine encephalitis viruses","volume":"189","author":"Reed","year":"2004","journal-title":"J Infect Dis"},{"issue":"2 (February)","key":"10.1016\/j.vaccine.2010.09.005_bib0110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0168-1702(02)00275-7","article-title":"Cytotoxic T-cell activity is not detectable in Venezuelan equine encephalitis virus-infected mice","volume":"91","author":"Jones","year":"2003","journal-title":"Virus Res"},{"issue":"2 (October 25)","key":"10.1016\/j.vaccine.2010.09.005_bib0115","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.virol.2007.05.041","article-title":"Alpha\u2013beta T cells provide protection against lethal encephalitis in the murine model of VEEV infection","volume":"367","author":"Paessler","year":"2007","journal-title":"Virology"},{"issue":"30 (June 19)","key":"10.1016\/j.vaccine.2010.09.005_bib0120","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/j.vaccine.2009.04.015","article-title":"CD4+ T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus","volume":"27","author":"Yun","year":"2009","journal-title":"Vaccine"},{"issue":"9 (May)","key":"10.1016\/j.vaccine.2010.09.005_bib0155","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1128\/JVI.02545-09","article-title":"T cells facilitate recovery from Venezuelan equine encephalitis virus-induced encephalomyelitis in the absence of antibody","volume":"84","author":"Brooke","year":"2010","journal-title":"J Virol"},{"issue":"9 (May)","key":"10.1016\/j.vaccine.2010.09.005_bib0130","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.09.005_bib0135","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1743-422X-6-118","article-title":"Improved efficacy of a gene optimised adenovirus-based vaccine for Venezuelan equine encephalitis virus","volume":"6","author":"Williams","year":"2009","journal-title":"J Virol"},{"issue":"40 (September 19)","key":"10.1016\/j.vaccine.2010.09.005_bib0140","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1016\/j.vaccine.2008.03.097","article-title":"Mixing of M segment DNA vaccines to Hantaan virus and Puumala virus reduces their immunogenicity in hamsters","volume":"26","author":"Spik","year":"2008","journal-title":"Vaccine"},{"issue":"4 (January 22)","key":"10.1016\/j.vaccine.2010.09.005_bib0145","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.vaccine.2009.10.111","article-title":"Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques","volume":"28","author":"Livingston","year":"2010","journal-title":"Vaccine"},{"issue":"5 (May)","key":"10.1016\/j.vaccine.2010.09.005_bib0150","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1586\/erv.10.42","article-title":"Electroporation for DNA immunization: clinical application","volume":"9","author":"van Drunen Littel-van den Hurk","year":"2010","journal-title":"Expert Rev Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10013009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10013009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T05:00:37Z","timestamp":1636520437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10013009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":30,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0264410X10013009"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.09.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}